LZ vs NBIX · P/E 54, rev $412.1M vs P/E 45, rev $1.77B
LegalZoom.com Inc (LZ) versus Neurocrine Biosciences Inc (NBIX) — a side-by-side from cached financials, not a winner call.
LegalZoom.com Inc (LZ) is a specialty business services company listed on US.
Neurocrine Biosciences Inc (NBIX) is a drug manufacturers - specialty & generic company listed on US.
Latest reported LZ revenue for 2026-06-30 was $412.1M. Net income was $6.3M. Revenue was up 99.3% from 2026-03-31 to 2026-06-30. LZ currently screens at market cap $1.65B and trailing P/E 53.6.
Latest reported NBIX revenue for 2026-06-30 was $1.77B. Net income was $342.3M. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
LZ currently screens at market cap $1.65B and trailing P/E 53.6. NBIX currently screens at market cap $13.21B and trailing P/E 45.2.
Not investment advice. Open the LZ and NBIX stock pages for the full models.
Not investment advice.